US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prospect Capital Corp

25.06

+0.0000

Volume:- -

Turnover:319.71K

Market Cap:9.22B

PE:68.17

High:25.06

Open:25.06

Low:25.06

Close:25.06

Loading ...

Overview Company News Filings

Investors Still Aren't Entirely Convinced By Zevia PBC's (NYSE:ZVIA) Revenues Despite 44% Price Jump

Simply Wall St.

Here's What Analysts Are Forecasting For Zevia PBC (NYSE:ZVIA) After Its Third-Quarter Results

Simply Wall St.

Prospect Capital Corp (PSEC) Q1 2025 Earnings Call Highlights: Strong Investment Income and ...

Zevia PBC Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

GENFIT Reports Third Quarter 2024 Financial Information

Zevia PBC Is Maintained at Market Perform by Telsey Advisory Group

Analysts Offer Insights on Consumer Goods Companies: Zevia PBC (ZVIA), Laird Superfood (LSF) and Vital Farms (VITL)

Loop Capital Markets Keeps Their Buy Rating on Zevia PBC (ZVIA)

Zevia PBC (ZVIA) Q3 2024 Earnings Call Highlights: Record Gross Margin and Strategic Expansion ...

Q3 2024 Zevia PBC Earnings Call

Thomson Reuters StreetEvents

Zevia PBC Reports Improved Earnings and Expanded Walmart Distribution

Zevia PBC (NYSE:ZVIA) Misses Q3 Revenue Estimates

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference

Zevia PBC (ZVIA) Reports Q3: Everything You Need To Know Ahead Of Earnings

Zevia PBC expected to post a loss of 8 cents a share - Earnings Preview

Tharimmune Announces Upcoming Conference Presentations

Telsey Advisory Reaffirms Their Hold Rating on Zevia PBC (ZVIA)

Zevia PBC Is Maintained at Market Perform by Telsey Advisory Group

Tharimmune Receives Positive Regulatory Feedback From EMA for TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PBC/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","market":"US","secType":"STK","nameCN":"Prospect Capital Corp","latestPrice":25.06,"timestamp":1640811600000,"preClose":25.06,"halted":4,"volume":0,"delay":0,"floatShares":0,"shares":367817926,"eps":0.367626,"marketStatus":"Delisted","change":0,"latestTime":"12-29 16:00:00 EST","open":25.06,"high":25.06,"low":25.06,"amount":319705.1613,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.367626,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.06,"dividendRate":0.028731,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","floatShares":0,"roa":"4.83%","roe":"4.16%","lyrEps":0.394789,"shares":367817926,"dividePrice":0.72,"high":25.06,"amplitude":0,"preClose":25.06,"low":25.06,"week52Low":25,"pbRate":"2.90","week52High":26.49,"institutionHeld":0,"latestPrice":25.06,"eps":0.367626,"divideRate":0.028731,"volume":0,"delay":0,"ttmEps":0.367626,"open":25.06},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBC\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2482402171","title":"Investors Still Aren't Entirely Convinced By Zevia PBC's (NYSE:ZVIA) Revenues Despite 44% Price Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2482402171","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482402171?lang=en_us&edition=fundamental","pubTime":"2024-11-09 22:24","pubTimestamp":1731162286,"startTime":"0","endTime":"0","summary":"Despite an already strong run, Zevia PBC ( NYSE:ZVIA ) shares have been powering on, with a gain of 44% in the last...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/5113000-choice2-main-header/1585186907028","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5113000-choice2-main-header/1585186907028"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-zvia/zevia-pbc/news/investors-still-arent-entirely-convinced-by-zevia-pbcs-nysez","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NYSE","PBC","ISBC","ZVIA"],"gpt_icon":0},{"id":"2482291514","title":"Here's What Analysts Are Forecasting For Zevia PBC (NYSE:ZVIA) After Its Third-Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2482291514","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482291514?lang=en_us&edition=fundamental","pubTime":"2024-11-09 21:57","pubTimestamp":1731160630,"startTime":"0","endTime":"0","summary":"The investors in Zevia PBC's  will be rubbing their hands together with glee today, after the share price leapt 32% to US$1.53 in the week following its third-quarter results. Results look to have been somewhat negative - revenue fell 6.8% short of analyst estimates at US$36m, although statutory losses were somewhat better. The per-share loss was US$0.04, 50% smaller than the analysts were expecting prior to the result. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Zevia PBC after the latest results.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WmufdV9.7qoiOmDt_SJToQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/70f6a2d423969c7bd844e7301d973d65","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WmufdV9.7qoiOmDt_SJToQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/70f6a2d423969c7bd844e7301d973d65"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-analysts-forecasting-zevia-pbc-135710707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4177","PBC","ZVIA","BK4539","NYSE"],"gpt_icon":0},{"id":"2482114284","title":"Prospect Capital Corp (PSEC) Q1 2025 Earnings Call Highlights: Strong Investment Income and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2482114284","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482114284?lang=en_us&edition=fundamental","pubTime":"2024-11-09 15:07","pubTimestamp":1731136025,"startTime":"0","endTime":"0","summary":"Net Investment Income : $89.9 million or $0.21 per common share.Net Asset Value : $3.51 billion or $8.10 per common share as of September 30.Unsecured Debt Plus Preferred: 86% of total debt plus preferred.Common Shareholder Distributions: $0.045 per share for November, December, and January.Interest Income as a Percent of Total Income: 94%, an increase of over 800 basis points year-over-year.First Lien Loans: 65% of total investments, up over 700 basis points year-over-year.Performing Interest Bearing Investments Yield: 11.8% annualized as of September.Portfolio at Fair Value: 64.9% first lien debt, 11.1% second lien debt, 6.2% subordinated structured notes, 17.8% unsecured debt and equity investments.Nonaccruals as a Percentage of Total Assets: Approximately 0.5% in September.Originations in September Quarter: $291 million, with net originations of $8 million.Unencumbered Assets: $4.9 billion, representing approximately 64% of the portfolio.Weighted Average Cost of Unsecured Debt Fina","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/prospect-capital-corp-psec-q1-070705728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSEC","PBC"],"gpt_icon":0},{"id":"2481217812","title":"Zevia PBC Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2481217812","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481217812?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:18","pubTimestamp":1731064682,"startTime":"0","endTime":"0","summary":"NYSE:ZVIA Earnings and Revenue Growth November 8th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 6.8%. Earnings per share  exceeded analyst estimates by 50%.Looking ahead, revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Beverage industry in the US.The company's share price is broadly unchanged from a week ago.We don't want to rain on the parade too much, but we did also find 3 warning signs for Zevia PBC that you need to be mindful of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zevia-pbc-third-quarter-2024-111802992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","ZVIA"],"gpt_icon":0},{"id":"2481193142","title":"GENFIT Reports Third Quarter 2024 Financial Information","url":"https://stock-news.laohu8.com/highlight/detail?id=2481193142","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481193142?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:10","pubTimestamp":1731013800,"startTime":"0","endTime":"0","summary":"Cash and cash equivalents totaled 96.0 million as of September 30, 2024. Of the 59.7 million in revenues for the first nine months of 2024, 48.7 million was attributable to a milestone payment invoiced to Ipsen in June 2024 and 0.9 million was attributable to royalty revenue from U.S. sales of Iqirvo/elafibranor which commenced mid-June in application of the Collaboration and License Agreement with Ipsen signed in December 2021. The remainder is comprised of 9.3 million attributable to the partial recognition of deferred income of 40 million accounted for in accordance with IFRS 15, in application of the aforementioned licensing agreement, and 0.8 million generated from the services rendered under the Transition Services Agreement and Part B Transition Services Agreement, signed in April 2022 and September 2023 respectively by GENFIT and Ipsen, in order to facilitate the transition of certain services related to the Phase 3 Elative2 clinical trial unt","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-reports-third-quarter-2024-211000360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4134","BK4139","GNFT","GNFTF","CCA","USA","PBC","III"],"gpt_icon":0},{"id":"2481188061","title":"Zevia PBC Is Maintained at Market Perform by Telsey Advisory Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2481188061","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481188061?lang=en_us&edition=fundamental","pubTime":"2024-11-07 22:09","pubTimestamp":1730988540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZVIA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 07, 2024 09:09 ET (14:09 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVIA","PBC","BK4539","BK4177"],"gpt_icon":0},{"id":"2481396188","title":"Analysts Offer Insights on Consumer Goods Companies: Zevia PBC (ZVIA), Laird Superfood (LSF) and Vital Farms (VITL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481396188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481396188?lang=en_us&edition=fundamental","pubTime":"2024-11-07 22:00","pubTimestamp":1730988019,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Zevia PBC (ZVIA – Research Report), Laird Superfood (LSF – Re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-zevia-pbc-zvia-laird-superfood-lsf-and-vital-farms-vitl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-zevia-pbc-zvia-laird-superfood-lsf-and-vital-farms-vitl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4212","VITL","BK4177","BK4539","ZVIA","LSF","PBC"],"gpt_icon":0},{"id":"2481290673","title":"Loop Capital Markets Keeps Their Buy Rating on Zevia PBC (ZVIA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481290673","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481290673?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:38","pubTimestamp":1730983122,"startTime":"0","endTime":"0","summary":"Loop Capital Markets analyst Alton Stump maintained a Buy rating on Zevia PBC (ZVIA – Research Report) today and set a price target of $2.00. The c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/loop-capital-markets-keeps-their-buy-rating-on-zevia-pbc-zvia?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/loop-capital-markets-keeps-their-buy-rating-on-zevia-pbc-zvia?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZVIA","PBC"],"gpt_icon":0},{"id":"2481923227","title":"Zevia PBC (ZVIA) Q3 2024 Earnings Call Highlights: Record Gross Margin and Strategic Expansion ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2481923227","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481923227?lang=en_us&edition=fundamental","pubTime":"2024-11-07 15:11","pubTimestamp":1730963486,"startTime":"0","endTime":"0","summary":"Adjusted EBITDA Loss: Improved to $1.5 million from $9.1 million in Q3 2023.Net Sales: $36.4 million, a 16% decline from Q3 2023.Annual Cost Savings: Expected to be $15 million, up from a previous estimate of $12 million.Net Loss: $2.8 million, improved from a net loss of $11.2 million in Q3 2023.Cash and Cash Equivalents: Approximately $32 million at the end of the quarter.Q4 2024 Sales Guidance: Expected to be between $38 million to $40 million.Q4 2024 Adjusted EBITDA Guidance: Expected to be between negative $1.8 million to negative $2.2 million.Full Year 2024 Net Sales Outlook: Between $154 million to $156 million.Full Year 2024 Adjusted EBITDA Loss: Approximately $13 million.Zevia PBC  reported a significant improvement in adjusted EBITDA loss, reducing it to $1.5 million from $9.1 million in the same quarter last year.Zevia PBC  is expanding its distribution to over 4,300 Walmart stores, which is expected to drive growth in the fourth quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zevia-pbc-zvia-q3-2024-071126418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","WMT","ZVIA"],"gpt_icon":0},{"id":"2481956944","title":"Q3 2024 Zevia PBC Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2481956944","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481956944?lang=en_us&edition=fundamental","pubTime":"2024-11-07 14:00","pubTimestamp":1730959252,"startTime":"0","endTime":"0","summary":"Greetings and welcome to the ZAP BC Q3 2024 earning school. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star then zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Reed Anderson from ICR. Please go ahead, sir.Thank you for joining our third quarter conference call particularly on the morning after the highly anticipated election. We are pleased with the vast improvement we delivered in Q3 adjusted even illustrating strong execution of our productivity initiative. While Q3 net sales were slightly below our expectations. We anticipate a return to growth in the fourth quarter, largely driven by our expansion in the 4,300 Walmart stores nationwide. We're excited about the rollout in Walmart and we remain confident in our long term potential. We","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q3-2024-zevia-pbc-earnings-060052785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["WMT","PBC","ZVIA"],"gpt_icon":0},{"id":"2481917661","title":"Zevia PBC Reports Improved Earnings and Expanded Walmart Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2481917661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481917661?lang=en_us&edition=fundamental","pubTime":"2024-11-07 12:59","pubTimestamp":1730955572,"startTime":"0","endTime":"0","summary":"Zevia Pbc Class A ( ($ZVIA) ) has released its Q3 earnings. Here is a breakdown of the information Zevia Pbc Class A presented to its investors. Ze...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zevia-pbc-reports-improved-earnings-and-expanded-walmart-distribution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zevia-pbc-reports-improved-earnings-and-expanded-walmart-distribution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZVIA","WMT","PBC"],"gpt_icon":0},{"id":"2481609474","title":"Zevia PBC (NYSE:ZVIA) Misses Q3 Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2481609474","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481609474?lang=en_us&edition=fundamental","pubTime":"2024-11-06 20:15","pubTimestamp":1730895345,"startTime":"0","endTime":"0","summary":"Beverage company Zevia  fell short of the market’s revenue expectations in Q3 CY2024, with sales falling 15.6% year on year to $36.37 million. Next quarter’s revenue guidance of $39 million underwhelmed, coming in 4.1% below analysts’ estimates. Its GAAP loss of $0.04 per share was 50% above analysts’ consensus estimates.Is now the time to buy Zevia PBC?Revenue: $36.37 million vs analyst estimates of $39.04 million . EBITDA: -$1.51 million vs analyst estimates of -$1.98 million . Revenue Guidance for Q4 CY2024 is $39 million at the midpoint, below analyst estimates of $40.65 million. EBITDA guidance for Q4 CY2024 is $2 million at the midpoint, above analyst estimates of -$1.02 million. Gross Margin : 49.1%, up from 45.4% in the same quarter last year. Operating Margin: -8.2%, up from -26.5% in the same quarter last year. EBITDA Margin: -4.1%, up from -21.2% in the same quarter last year. This quarter, Zevia PBC missed Wall Street’s estimates and reported a rather uninspiring 15.6% year","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/13ATwFYDNxeIR3FD3qYODw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/23b501c60a806c654ca578c0e12065fb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/13ATwFYDNxeIR3FD3qYODw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/23b501c60a806c654ca578c0e12065fb"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zevia-pbc-nyse-zvia-misses-121545753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZVIA","PBC","NYSE"],"gpt_icon":0},{"id":"2481885654","title":"United Therapeutics Corporation to Present at the UBS Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2481885654","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481885654?lang=en_us&edition=fundamental","pubTime":"2024-11-06 05:30","pubTimestamp":1730842200,"startTime":"0","endTime":"0","summary":"At United Therapeutics, our vision and mission are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good. We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation . Our public benefit purpose is to provide a brighter future for patients through  the development of novel pharmaceutical therapies; and  technologies that expand the availability of transplantable organs.You can learn more about what it means to be a PBC here: unither.com/pbc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/united-therapeutics-corporation-present-ubs-213000222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","UTHR","LU1571399168.USD","HCSG","LU1699723380.USD","BK4137","BK4139","BK4532"],"gpt_icon":0},{"id":"2481057505","title":"Zevia PBC (ZVIA) Reports Q3: Everything You Need To Know Ahead Of Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2481057505","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481057505?lang=en_us&edition=fundamental","pubTime":"2024-11-05 15:11","pubTimestamp":1730790668,"startTime":"0","endTime":"0","summary":"Beverage company Zevia  will be reporting earnings tomorrow before market open. Here’s what investors should know.Zevia PBC beat analysts’ revenue expectations by 3.8% last quarter, reporting revenues of $40.43 million, down 4.3% year on year. It was a softer quarter for the company, with a miss of analysts’ operating margin estimates.Is Zevia PBC a buy or sell going into earnings?Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/13ATwFYDNxeIR3FD3qYODw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/23b501c60a806c654ca578c0e12065fb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/13ATwFYDNxeIR3FD3qYODw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/23b501c60a806c654ca578c0e12065fb"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zevia-pbc-zvia-reports-q3-071108915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZVIA","PBC"],"gpt_icon":0},{"id":"2480458040","title":"Zevia PBC    expected to post a loss of 8 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2480458040","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480458040?lang=en_us&edition=fundamental","pubTime":"2024-11-04 23:44","pubTimestamp":1730735091,"startTime":"0","endTime":"0","summary":"* Zevia PBC     is expected to show a fall in quarterly revenue when it reports  results on November 6 for the period ending September 30 2024   * The Encino California-based  company is expected to r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVIA","PBC"],"gpt_icon":0},{"id":"2480586212","title":"Tharimmune Announces Upcoming Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2480586212","media":"ACCESSWIRE","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480586212?lang=en_us&edition=fundamental","pubTime":"2024-11-04 22:00","pubTimestamp":1730728800,"startTime":"0","endTime":"0","summary":"BRIDGEWATER, NJ / ACCESSWIRE / November 4, 2024 / Tharimmune, Inc.  , a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announces that management will be participating in two upcoming conferences.Randy Milby, Chief Executive Officer, will attend the 2024 Spartan Capital Investor Conference being held on November 4, 2024 in New York and hold one-on-one meetings. Interested investors can register to attend the conference and schedule meetings here.Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, contained in this press release, including statements regarding the timing and design of Tharimmune's future Phase 2 trial, Tharimmune's strategy, future operations, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking stateme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tharimmune-announces-upcoming-conference-presentations-140000877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","BK4139","THAR"],"gpt_icon":1},{"id":"2480583571","title":"Telsey Advisory Reaffirms Their Hold Rating on Zevia PBC (ZVIA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2480583571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480583571?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:37","pubTimestamp":1730727444,"startTime":"0","endTime":"0","summary":"In a report released today, Joe Feldman from Telsey Advisory maintained a Hold rating on Zevia PBC (ZVIA – Research Report), with a price target of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/telsey-advisory-reaffirms-their-hold-rating-on-zevia-pbc-zvia?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/telsey-advisory-reaffirms-their-hold-rating-on-zevia-pbc-zvia?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBC","ZVIA"],"gpt_icon":0},{"id":"2480305435","title":"Zevia PBC Is Maintained at Market Perform by Telsey Advisory Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2480305435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480305435?lang=en_us&edition=fundamental","pubTime":"2024-11-04 19:21","pubTimestamp":1730719260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZVIA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 04, 2024 06:21 ET (11:21 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","PBC","ZVIA","BK4177"],"gpt_icon":0},{"id":"2479025492","title":"Tharimmune Receives Positive Regulatory Feedback From EMA for TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2479025492","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479025492?lang=en_us&edition=fundamental","pubTime":"2024-10-30 20:00","pubTimestamp":1730289600,"startTime":"0","endTime":"0","summary":"BRIDGEWATER, NJ / ACCESSWIRE / October 30, 2024 / Tharimmune, Inc.  , a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, received positive feedback from a Scientific Advice meeting with the European Medicines Agency  that included guidance on a planned Phase 2 trial to advance TH104, the Company's lead clinical-stage candidate for moderate-to-severe pruritus in primary biliary cholangitis .The EMA interactions specifically focused on both the Phase 2 and Phase 3 clinical program of TH104. Overall, the Agency noted that using Article 10, hybrid application, is acceptable and could enable referring to non-clinical and some safety data from the approved products. Regarding non-clinical information provided, the Agency endorsed the strategy presented by the Company and noted that there is no need to conduct additional animal studies and considered human exposure to be adequate to move forward. The Agency found the design ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tharimmune-receives-positive-regulatory-feedback-120000811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBC","BK4139","THAR"],"gpt_icon":0},{"id":"2479272740","title":"United Therapeutics Corporation Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2479272740","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479272740?lang=en_us&edition=fundamental","pubTime":"2024-10-30 18:30","pubTimestamp":1730284200,"startTime":"0","endTime":"0","summary":"SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., October 30, 2024----United Therapeutics Corporation , a public benefit corporation, today announced its financial results for the quarter ended September 30, 2024. Total revenues in the third quarter of 2024 grew 23 percent year-over-year to $748.9 million, compared to $609.4 million in the third quarter of 2023.Michael Benkowitz, President and Chief Operating Officer of United Therapeutics, added, \"Our team’s efforts have once again translated into outstanding financial results, achieving record revenue for a sixth straight quarter that underscores the increasing demand for our innovative products serving pulmonary hypertension and high-risk neuroblastoma patients. Tyvaso remains our biggest near-term growth driver, and we are encouraged by the underlying dynamics driving its continued uptake in pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/united-therapeutics-corporation-reports-third-103000371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BD4GTV84.USD","IE00BMG7P587.USD","LU1571399168.USD","PBC","UTHR","IE00BMG7P694.USD","IE00BD4GTW91.USD","IE00BMG7P819.SGD","IE00BD4GTT62.SGD","ETR","LU1699723380.USD","BK4532","IE00BMG7P702.HKD","BK4081","BK4588","BK4585","BK4139","IE00BMG7P926.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":145,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-30","symbol":"PBC","reason":null,"defaultRemindTime":1640874600000,"announcedDate":"2021-12-01","type":"delisting","dateTimestamp":1640840400000},{"market":"US","date":"2021-11-30","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1638282600000,"name":"Prospect Capital Corp","recordDate":"2021-12-15","payableDate":"2021-12-01","currency":"USD","type":"dividend","dateTimestamp":1638248400000},{"market":"US","date":"2021-08-31","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1630416600000,"name":"Prospect Capital Corp","recordDate":"2021-09-15","payableDate":"2021-09-01","currency":"USD","type":"dividend","dateTimestamp":1630382400000},{"market":"US","date":"2021-05-28","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1622208600000,"name":"Prospect Capital Corp","recordDate":"2021-06-15","payableDate":"2021-06-01","currency":"USD","type":"dividend","dateTimestamp":1622174400000},{"market":"US","date":"2021-02-26","symbol":"PBC","amount":0.4296875,"name":"Prospect Capital Corp","recordDate":"2021-03-15","payableDate":"2021-03-01","currency":"USD","type":"dividend","dateTimestamp":1614315600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBC\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":"2019-03-01","paymentDate":"2019-03-15","value":0.4774306,"currency":"USD"},{"executeDate":"2019-08-29","recordDate":"2019-08-30","paymentDate":"2019-09-15","value":0.4296875,"currency":"USD"},{"executeDate":"2019-11-27","recordDate":"2019-11-29","paymentDate":"2019-12-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":"2020-03-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-05-29","recordDate":"2020-06-01","paymentDate":"2020-06-15","value":0.4296875,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBC\",market:\"US\",delay:false,,,undefined,":{}}}